STAT

Sarepta halts early-stage gene therapy trial for DMD

A stray DNA fragment was found "in connection with routine quality assurance testing" of the plasmids used in the company's gene therapy.

Sarepta Therapeutics’ clinical trial for a gene therapy to treat Duchenne muscular dystrophy has been paused by the Food and Drug Administration because some of the materials used in the treatment weren’t as they should be, the company announced Wednesday.

A stray

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readSociety
More Than 15% Of U.S. Adults Are Physically Inactive, New CDC Data Show
More than 1 in 7 adults across all U.S. states and territories are physically inactive, new CDC data show.
STAT6 min read
Opinion: Goop’s Pseudoscience Ministry Comes To Netflix
Gwyneth Paltrow's Goop has embraced mediums and mysticism. With spirits and the divine on board, "The Goop Lab" on Netflix has the missing ingredients to cement lifestyle as the new…
STAT6 min read
‘Donation After Cardiac Death’: New Heart Transplant Method Being Tested For The First Time In The U.S.
A new method of “reanimating” donor hearts from those who have died from cardiac failure is being tested in the U.S. and may be able to expand amount of people…